Table 4. Descriptive statistics for the received treatments at the time of the study.
| Total(n=101) | |
|---|---|
| Number of treatments | |
| Mean (SD) | 13.2 (4.8) |
| Median (IQR) | 13 (11 –16) |
| Range | 0 – 31 |
| Number of inhalers | |
| Mean (SD) | 2 (1.2) |
| Median (IQR) | 2 (1 – 3) |
| Range | 0 – 5 |
| Number of nebulizers | |
| Mean (SD) | 2.3 (1.1) |
| Median (IQR) | 2 (2 – 3) |
| Range | 0 – 5 |
| Number of chest physiotherapies | |
| Mean (SD) | 1.5 (0.6) |
| Median (IQR) | 1 (1 – 2) |
| Range | 0 – 3 |
| Type of primary chest physiotherapy, n (%) | |
| Autogenic drainage | 36 (35.6%) |
| Active cycle breathing techniques | 21 (20.8%) |
| Oscillating PEP | 21 (20.8%) |
| Other | 13 (12.9%) |
| None | 10 (9.9%) |
| Inhaled medication time in minutes (min/day) | |
| Mean (SD) | 42.6 (38.2) |
| Median (IQR) | 30 (20 – 60) |
| Range | 0 – 180 |
| Chest physiotherapy time in minutes (min/day) | |
| Mean (SD) | 36.3 (31.8) |
| Median (IQR) | 30 (17.5 – 50) |
| Range | 0 – 180 |
| Other treatments time in minutes (min/day) | |
| Mean (SD) | 12 (20) |
| Median (IQR) | 5 (0 – 15) |
| Range | 0 – 120 |
| Total treatment time in minutes (min/day) | |
| Mean (SD) | 91 (70.7) |
| Median (IQR) | 80 (45 – 108.5) |
| Range | 0 – 420 |
| TCS (treatment complexity score) | |
| Mean (SD) | 22 (7.4) |
| Median (IQR) | 23 (18 – 27) |
| Range | 0 – 40 |
| CFTR Modulators, n (%), | |
| On CFTR modulator | 66 (65.3%) |
| On
Elexacaftor/tezacaftor/ivacaftor (Trikafta/Kaftrio©) |
33 (32.7%) |